Kintor Pharmaceutical Limited (KNTPF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.06 Billion CNY | -11.15% |
| 2022 | -954.36 Million CNY | -13.33% |
| 2021 | -842.09 Million CNY | -65.67% |
| 2020 | -508.3 Million CNY | -118.55% |
| 2019 | -232.57 Million CNY | -114.39% |
| 2018 | -108.48 Million CNY | -134.73% |
| 2017 | -46.21 Million CNY | 14.77% |
| 2016 | -54.22 Million CNY | -373.96% |
| 2015 | -11.44 Million CNY | -37.09% |
| 2014 | -8.34 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -4950.70 USD | 100.0% |
| 2024 Q2 | -4918.75 USD | 0.65% |
| 2023 FY | -1.06 Billion CNY | -11.15% |
| 2023 Q3 | -58.12 Thousand USD | 99.81% |
| 2023 Q1 | -15.44 Thousand USD | 99.98% |
| 2023 Q2 | -30.6 Million USD | -198065.42% |
| 2023 Q4 | -117.38 Million USD | -201868.2% |
| 2022 Q4 | -62.61 Million USD | 0.0% |
| 2022 FY | -954.36 Million CNY | -13.33% |
| 2022 Q2 | -79.75 Million USD | 0.0% |
| 2021 Q4 | -80.12 Million USD | 0.0% |
| 2021 FY | -842.09 Million CNY | -65.67% |
| 2021 Q2 | -50.34 Million USD | 0.0% |
| 2020 Q4 | -46.16 Million USD | 0.0% |
| 2020 FY | -508.3 Million CNY | -118.55% |
| 2020 Q2 | -27.82 Million USD | 0.0% |
| 2019 Q2 | -14.57 Million USD | 0.0% |
| 2019 Q4 | -19.15 Million USD | 0.0% |
| 2019 FY | -232.57 Million CNY | -114.39% |
| 2018 FY | -108.48 Million CNY | -134.73% |
| 2017 FY | -46.21 Million CNY | 14.77% |
| 2016 FY | -54.22 Million CNY | -373.96% |
| 2015 FY | -11.44 Million CNY | -37.09% |
| 2014 FY | -8.34 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | -3.17 Million USD | -33349.201% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -28491.728% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -44455.982% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 2102.341% |
| GB Sciences, Inc. | -1.36 Million USD | -77805.406% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -34955.277% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -464912.909% |
| Skye Bioscience, Inc. | -37.64 Million USD | -2717.973% |
| Zenith Capital Corp. | -10.59 Million USD | -9911.514% |
| Agentix Corp. | -1.37 Million USD | -77094.841% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -15091.822% |
| Biomind Labs Inc. | -1.21 Million USD | -87259.252% |
| ContraFect Corporation | -65.15 Million USD | -1528.198% |
| CSL Limited | 2.64 Billion USD | 140.152% |
| CytoDyn Inc. | -49.84 Million USD | -2028.408% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -54321.985% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -167643.241% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | -1594.628% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -255224.577% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -58169.909% |
| Regen BioPharma, Inc. | 1.02 Million USD | 103745.502% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 1728.7% |
| SQZ Biotechnologies Company | -79.46 Million USD | -1234.969% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -48789.905% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | -1315.125% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -36576.193% |
| Mesoblast Limited | -87.95 Million USD | -1106.08% |
| Marizyme, Inc. | -65.34 Million USD | -1523.367% |
| Genus plc | 7.9 Million USD | 13528.101% |
| Pharming Group N.V. | -10.54 Million USD | -9957.072% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -11894.799% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -61309.414% |
| IMV Inc. | -36.48 Million USD | -2807.496% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -13062.058% |
| MultiCell Technologies, Inc. | -380.07 USD | -279111642.574% |
| ONE Bio Corp. | 8.67 Million USD | 12326.201% |
| RVL Pharmaceuticals plc | -51.69 Million USD | -1952.194% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -28317.359% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -34100.495% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -13322.846% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -7083366.88% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | -6583.828% |
| Alpha Cognition Inc. | -13.77 Million USD | -7602.413% |
| Enzolytics Inc. | -2.17 Million USD | -48632.286% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | -259.535% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 1082569.388% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 15419.599% |
| Genscript Biotech Corporation | -95.47 Million USD | -1011.074% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -16031.419% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -387907.403% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -25486.984% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -1755044.43% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -52805.694% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -9639.673% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -21611.14% |
| Adynxx, Inc. | - USD | Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -28215.573% |
| Helix BioMedix, Inc. | -1.05 Million USD | -100351.017% |
| EV Biologics, Inc. | -1.26 Million USD | -83618.06% |
| Q BioMed Inc. | -2.05 Million USD | -51594.538% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -27677.429% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | -1676.162% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| BioStem Technologies, Inc. | -8.48 Million USD | -12405.269% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -18135.755% |
| HST Global, Inc. | -146.21 Thousand USD | -725445.448% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -79336.526% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -60353.472% |
| Halberd Corporation | -79.67 Thousand USD | -1331317.24% |
| Resverlogix Corp. | -3.61 Million USD | -29285.596% |
| Cell Source, Inc. | -5.32 Million USD | -19835.684% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -26600.777% |
| GeneThera, Inc. | - USD | Infinity% |
| AVAX Technologies, Inc. | -6.41 Million USD | -16440.041% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -4564137.157% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -4.76 Million USD | -22143.204% |
| Kadimastem Ltd | -3.3 Million USD | -31974.156% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -23778.709% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -240247.646% |
| LadRx Corporation | 400.44 Thousand USD | 265011.61% |
| Regen BioPharma, Inc. | 1.02 Million USD | 103745.502% |
| Affymax, Inc. | -14.42 Million USD | -7254.548% |
| Itoco Inc. | -1.86 Million USD | -56658.846% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -63460.216% |
| Mobile Lads Corp. | -2.26 Million USD | -46770.665% |
| International Stem Cell Corporation | -131 Thousand USD | -809686.26% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| Bioxytran, Inc. | -4.28 Million USD | -24685.502% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -1342149.44% |
| Qrons Inc. | -789.34 Thousand USD | -134292.099% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -112569.923% |
| SYBLEU INC | -180.3 Thousand USD | -588250.785% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -50713.294% |
| Rebus Holdings, Inc. | -1.02 Million USD | -103901.961% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -65677.619% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -1954535.908% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -41825.551% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | -2106.732% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -50080.7% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -135748.08% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -33385.48% |
| Neutra Corp. | -233.46 Thousand USD | -454280.742% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -5128.032% |
| PureTech Health plc | -65.69 Million USD | -1514.716% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | -4888.212% |
| IXICO plc | -1.17 Million USD | -89952.632% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -10586.209% |
| Gelesis Holdings, Inc. | -57.12 Million USD | -1756.918% |
| CSL Limited | 2.64 Billion USD | 140.152% |
| Cellectis S.A. | -103.17 Million USD | -928.187% |